Carlisle Companies Incorporated (CSL)

Gross profit margin

Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Gross profit US$ in thousands 1,634,200 1,866,000 464,800 389,600 1,371,700
Revenue US$ in thousands 4,586,900 5,449,400 4,810,300 3,969,900 4,484,600
Gross profit margin 35.63% 34.24% 9.66% 9.81% 30.59%

December 31, 2023 calculation

Gross profit margin = Gross profit ÷ Revenue
= $1,634,200K ÷ $4,586,900K
= 35.63%

The gross profit margin of Carlisle Companies Inc. has exhibited a generally positive trend over the past five years, increasing from 28.51% in 2019 to 35.63% in 2023. This indicates that the company has been able to effectively control its cost of goods sold relative to its total revenue, resulting in a higher percentage of revenue remaining as gross profit. The steady improvement in the gross profit margin suggests that Carlisle Companies Inc. has been successful in optimizing its production processes, managing input costs, and potentially increasing prices to customers. Overall, the rising trend in the gross profit margin reflects positively on the company's operational efficiency and profitability.


Peer comparison

Dec 31, 2023

Company name
Symbol
Gross profit margin
Carlisle Companies Incorporated
CSL
35.63%
West Pharmaceutical Services Inc
WST
38.69%